Renalytix AI plc(RNLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RNLX Renalytix AI plc

Market Closed 10-04 16:00:00 EDT

0.1960

+0.0140

+7.69%

盘后0.1909

-0.0051-2.60%

19:47 EDT

High0.2000	Low0.1760	Vol284.52K
Open0.1890	D1 Closing0.1820	Amplitude13.19%
Mkt Cap16.26M	Tradable Cap11.21M	Total Shares82.96M
T/O51.74K	T/O Rate0.50%	Tradable Shares57.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"RNLX","market":"US","secType":"STK","nameCN":"Renalytix AI plc","latestPrice":0.196,"timestamp":1728072000000,"preClose":0.182,"halted":0,"volume":284521,"hourTrading":{"tag":"盘后","latestPrice":0.1909,"preClose":0.196,"latestTime":"19:47 EDT","volume":6708,"amount":1321.6299,"timestamp":1728085674573},"delay":0,"floatShares":57171899,"shares":82962800,"eps":-0.386161,"marketStatus":"Market Closed","change":0.014,"latestTime":"10-04 16:00:00 EDT","open":0.189,"high":0.2,"low":0.176,"amount":51742.85248992,"amplitude":0.131868,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.386161,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1728288000000},"marketStatusCode":7,"adr":0,"adrRate":2,"listingDate":1594958400000,"exchange":"NASDAQ","adjPreClose":0.182,"preHourTrading":{"tag":"盘前","latestPrice":0.182,"preClose":0.182,"latestTime":"09:05 EDT","volume":251,"amount":46.78199997,"timestamp":1728047139945},"postHourTrading":{"tag":"盘后","latestPrice":0.1909,"preClose":0.196,"latestTime":"19:47 EDT","volume":6708,"amount":1321.6299,"timestamp":1728085674573},"volumeRatio":0.5405136914677198,"impliedVol":0.5001,"impliedVolPercentile":0.2619},"requestUrl":"/m/hq/s/RNLX","defaultTab":"news","newsList":[{"id":"2451655133","title":"Renalytix Price Target Maintained With a $3.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451655133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2451655133?lang=en_us&edition=fundamental","pubTime":"2024-07-13 01:52","pubTimestamp":1720806720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 12, 2024 13:52 ET (17:52 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNLX"],"gpt_icon":0},{"id":"2450300273","title":"Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US","url":"https://stock-news.laohu8.com/highlight/detail?id=2450300273","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450300273?lang=en_us&edition=fundamental","pubTime":"2024-07-11 19:00","pubTimestamp":1720695600,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, July  11, 2024  (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical manag","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/07/11/2911676/0/en/Renalytix-and-Steno-Diabetes-Center-Announce-Precision-Medicine-Collaboration-Marking-First-Expansion-for-KidneyIntelX-Platform-Beyond-US.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNLX","BK4585","BK4588","BK4167","BK4178"],"gpt_icon":0},{"id":"2446552120","title":"Renalytix Requests Hearing With Nasdaq to Maintain Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2446552120","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446552120?lang=en_us&edition=fundamental","pubTime":"2024-06-28 15:32","pubTimestamp":1719559960,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["QID","QQQ","LU2095319765.USD","NDAQ","BK4117","BK4107",".IXIC","AFG","RNLX","MNQmain","TQQQ","PSQ","BK4585","QLD","SQQQ","BK4112","BK4167","NQmain","BK4588","LU2210150020.SGD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2446214405","title":"Renalytix Requests Hearing With Nasdaq to Maintain Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2446214405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446214405?lang=en_us&edition=fundamental","pubTime":"2024-06-28 15:32","pubTimestamp":1719559960,"startTime":"0","endTime":"0","summary":"Renalytix  said Thursday it has submitted a request for a hearing with Nasdaq to present a plan to regain compliance with the stock market's listing requirements.The company said it has been notified that it has been out of compliance with Nasdaq minimum closing share price and market value requirements.The hearing request automatically stays any suspension or delisting procedures, and the company's American Depositary Shares will continue trading on Nasdaq.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","NQmain","RNLX","MNQmain","SQQQ","NDAQ","LU2210150020.SGD","TQQQ","BK4112",".IXIC","PSQ","LU2095319765.USD","LU2210149790.SGD","QID","QLD","QQQ","BK4588","BK4167"],"gpt_icon":0},{"id":"2446997505","title":"Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination","url":"https://stock-news.laohu8.com/highlight/detail?id=2446997505","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2446997505?lang=en_us&edition=fundamental","pubTime":"2024-06-28 06:30","pubTimestamp":1719527400,"startTime":"0","endTime":"0","summary":"Throughout the hearings process and pending the Panel’s decision, the Company’s ADSs will continue trading on The Nasdaq Global Market under the symbol “RNLX”LONDONandNEW YORK, June  27, 2024  (GLOBE ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/27/2905606/0/en/Renalytix-Submits-Hearing-Request-to-Nasdaq-Hearings-Panel-in-Regard-to-Staff-Delisting-Determination.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","SQQQ","A","LU2210149790.SGD","BK4567","PSQ",".IXIC","BK4167","RNLX","MNQmain","LU1543694498.USD","NDAQ","LU1165135440.EUR","QLD","BK4121","LU2210150020.SGD","LU2095319765.USD","LU2092937221.SGD","TQQQ","BK4588","QQQ","LU2041044095.USD","BK4112","LU1721428933.USD","QID","NQmain"],"gpt_icon":0},{"id":"2444114032","title":"Renalytix AI’s KidneyIntelX Gains Medicare Coverage Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2444114032","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2444114032?lang=en_us&edition=fundamental","pubTime":"2024-06-18 05:07","pubTimestamp":1718658471,"startTime":"0","endTime":"0","summary":"Renalytix AI (RNLX) just unveiled an announcement. Renalytix plc announced a significant milestone as Medicare issued its final coverage determinat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-ais-kidneyintelx-gains-medicare-coverage-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-ais-kidneyintelx-gains-medicare-coverage-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNLX","BK4167"],"gpt_icon":0},{"id":"2443621736","title":"Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2443621736","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443621736?lang=en_us&edition=fundamental","pubTime":"2024-06-14 20:22","pubTimestamp":1718367766,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4167","RNLX"],"gpt_icon":0},{"id":"2443212176","title":"Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2443212176","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443212176?lang=en_us&edition=fundamental","pubTime":"2024-06-14 20:22","pubTimestamp":1718367766,"startTime":"0","endTime":"0","summary":"Renalytix  said Friday that Medicare issued a final Local Coverage Determination for its kidneyintelX.dkd test a day earlier. As of Aug. 1, the test will be covered by Medicare for patients with diagnosed type 2 diabetes and stage 1-3b chronic kidney disease as \"reasonable and necessary,\" the company said.The Medicare coverage of KidneyintelX.dkd, which will cost $950 per test, will \"prompt additional major coverage decisions\" and support expedited testing adoption, Renalytix CEO James McCullough said.Renalytix shares were up more than 10% in recent Friday premarket activity.Price: 0.5200, Change: +0.05, Percent Change: +10.90","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RNLX","BK4167"],"gpt_icon":0},{"id":"2443287676","title":"Medicare Issues Final Coverage Determination for kidneyintelX.dkd","url":"https://stock-news.laohu8.com/highlight/detail?id=2443287676","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443287676?lang=en_us&edition=fundamental","pubTime":"2024-06-14 19:00","pubTimestamp":1718362800,"startTime":"0","endTime":"0","summary":"Company has Achieved Prerequisites for Growing Test Adoption with FDA Authorization, Clinical Outcomes Data, Inclusion in Clinical Guidelines, and Broad Insurance CoverageLONDONandNEW YORK, June  14, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/06/14/2898900/0/en/Medicare-Issues-Final-Coverage-Determination-for-kidneyintelX-dkd.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","RNLX"],"gpt_icon":0},{"id":"2443257513","title":"Renalytix AI Appoints Joel R. Jung as Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2443257513","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443257513?lang=en_us&edition=fundamental","pubTime":"2024-06-13 05:59","pubTimestamp":1718229570,"startTime":"0","endTime":"0","summary":"An update from Renalytix AI (RNLX) is now available. Renalytix plc has appointed Joel R. Jung as the Interim Chief Financial Officer following O. J...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-ai-appoints-joel-r-jung-as-interim-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-ai-appoints-joel-r-jung-as-interim-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNLX","BK4167"],"gpt_icon":0},{"id":"2441390791","title":"Renalytix Files Registration Statement on Behalf of Selling Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2441390791","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441390791?lang=en_us&edition=fundamental","pubTime":"2024-06-06 18:06","pubTimestamp":1717668401,"startTime":"0","endTime":"0","summary":"Renalytix (RNLX) filed Wednesday a registration statement for the potential offering of up to 26.8 million ordinary shares, including in the form of American depositary shares, by certain selling stockholders.The company will not receive any proceeds from the secondary offering.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4167","RNLX"],"gpt_icon":0},{"id":"2441369791","title":"Renalytix Files Registration Statement on Behalf of Selling Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2441369791","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2441369791?lang=en_us&edition=fundamental","pubTime":"2024-06-06 18:06","pubTimestamp":1717668401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["RNLX","BK4107","BK4117","BK4167","AFG"],"gpt_icon":0},{"id":"2436761231","title":"Renalytix AI (RNLX) Gets a Buy from BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2436761231","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2436761231?lang=en_us&edition=fundamental","pubTime":"2024-05-20 18:27","pubTimestamp":1716200849,"startTime":"0","endTime":"0","summary":"BTIG analyst Mark Massaro maintained a Buy rating on Renalytix AI (RNLX – Research Report) today and set a price target of $2.00. The company’s sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/renalytix-ai-rnlx-gets-a-buy-from-btig-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/renalytix-ai-rnlx-gets-a-buy-from-btig-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNLX","BK4167"],"gpt_icon":0},{"id":"2435565635","title":"Renalytix Q3 2024 GAAP EPS $(0.08) Misses $(0.07) Estimate, Sales $535.000 Miss $950.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2435565635","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435565635?lang=en_us&edition=fundamental","pubTime":"2024-05-15 19:02","pubTimestamp":1715770929,"startTime":"0","endTime":"0","summary":"Renalytix Q3 2024 GAAP EPS $(0.08) Misses $(0.07) Estimate, Sales $535.000 Miss $950.000K Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38838955/renalytix-q3-2024-gaap-eps-0-08-misses-0-07-estimate-sales-535-000-miss-950-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNLX"],"gpt_icon":0},{"id":"2435633708","title":"Renalytix 3Q Rev $535,000 >RNLX","url":"https://stock-news.laohu8.com/highlight/detail?id=2435633708","media":"DowjonesLive","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435633708?lang=en_us&edition=fundamental","pubTime":"2024-05-15 19:02","pubTimestamp":1715770920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"dowjones_live","symbols":["RNLX","BK4167"],"gpt_icon":0},{"id":"2435355536","title":"Renalytix 3Q Loss/Shr 8c >RNLX","url":"https://stock-news.laohu8.com/highlight/detail?id=2435355536","media":"DowjonesLive","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435355536?lang=en_us&edition=fundamental","pubTime":"2024-05-15 19:01","pubTimestamp":1715770860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"dowjones_live","symbols":["RNLX","BK4167"],"gpt_icon":0},{"id":"2435635680","title":"Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2435635680","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2435635680?lang=en_us&edition=fundamental","pubTime":"2024-05-15 11:00","pubTimestamp":1715742000,"startTime":"0","endTime":"0","summary":"LONDON and NEW YORK, May  15, 2024  (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical manage","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/15/2882289/0/en/Renalytix-Reports-Financial-Results-for-Third-Quarter-of-Fiscal-Year-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4179","BK4167","RNLX","NGS"],"gpt_icon":0},{"id":"2434009386","title":"Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15","url":"https://stock-news.laohu8.com/highlight/detail?id=2434009386","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2434009386?lang=en_us&edition=fundamental","pubTime":"2024-05-09 19:00","pubTimestamp":1715252400,"startTime":"0","endTime":"0","summary":"Conference Call Details:To participate in the live conference call via telephone, please registerhere. Upon registering, a dial-in number and unique PIN will be provided in order for interested parties to join the conference call.Alex Price / Nicholas Moore / Nick Harland / Samira Essebiyea","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pDuaAoamiVde6M3zrLVB8A--~B/aD04MDA7dz0xOTY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/89ae80a1870dde2f9907db26cadd9614","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pDuaAoamiVde6M3zrLVB8A--~B/aD04MDA7dz0xOTY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/89ae80a1870dde2f9907db26cadd9614"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/renalytix-report-financial-results-third-110000560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4561","BK4590","BK4585","RNLX","BK4144","ET","BK4167","BST","BK4588","BK4581"],"gpt_icon":1},{"id":"2429401551","title":"Renalytix AI Announces Fundraising, Executive Changes, and Shareholder Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2429401551","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2429401551?lang=en_us&edition=fundamental","pubTime":"2024-04-24 05:13","pubTimestamp":1713906820,"startTime":"0","endTime":"0","summary":"Renalytix AI (RNLX) just unveiled an update. Renalytix plc successfully raised approximately $0.5 million in a registered direct offering by sellin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-ai-announces-fundraising-executive-changes-and-shareholder-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-ai-announces-fundraising-executive-changes-and-shareholder-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNLX","BK4167"],"gpt_icon":0},{"id":"2429187978","title":"Renalytix: All Resolutions Were Passed at General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2429187978","media":"DowjonesLive","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2429187978?lang=en_us&edition=fundamental","pubTime":"2024-04-22 23:10","pubTimestamp":1713798600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"dowjones_live","symbols":["BK4167","RNLX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renalytixai.com","stockEarnings":[{"period":"1week","weight":-0.2513},{"period":"1month","weight":-0.3356},{"period":"3month","weight":-0.2377},{"period":"6month","weight":-0.755},{"period":"1year","weight":-0.8526},{"period":"ytd","weight":-0.4974}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.04},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.1052},{"period":"1year","weight":0.3498},{"period":"ytd","weight":0.2055}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products in connection with the application of artificial intelligence for the diagnosis of kidney disease; Joslin Diabetes Center, Inc. for developing and commercializing products for diagnosing and predicting kidney disease using biomarkers; and Kantaro Biosciences LLC for developing and commercializing laboratory tests for the detection of antibodies against SARS-CoV-2. The company also has a partnership agreement with Atrium Health, Wake Forest Baptist Health, and Wake Forest School of Medicine to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations. The company was formerly known as Renalytix AI plc and changed its name to Renalytix Plc in June 2021. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.209435},{"month":2,"riseRate":0.5,"avgChangeRate":0.621813},{"month":3,"riseRate":0.25,"avgChangeRate":-0.177704},{"month":4,"riseRate":0.25,"avgChangeRate":-0.069914},{"month":5,"riseRate":0.5,"avgChangeRate":-0.132964},{"month":6,"riseRate":0.25,"avgChangeRate":-0.170639},{"month":7,"riseRate":0.5,"avgChangeRate":0.2318},{"month":8,"riseRate":0.4,"avgChangeRate":-0.102323},{"month":9,"riseRate":0,"avgChangeRate":-0.330697},{"month":10,"riseRate":0.6,"avgChangeRate":0.09009},{"month":11,"riseRate":0.5,"avgChangeRate":-0.187541},{"month":12,"riseRate":0.25,"avgChangeRate":-0.053499}],"exchange":"NASDAQ","name":"Renalytix AI plc","nameEN":"Renalytix AI plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Renalytix AI plc(RNLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Renalytix AI plc(RNLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Renalytix AI plc,RNLX,Renalytix AI plc股票,Renalytix AI plc股票老虎,Renalytix AI plc股票老虎国际,Renalytix AI plc行情,Renalytix AI plc股票行情,Renalytix AI plc股价,Renalytix AI plc股市,Renalytix AI plc股票价格,Renalytix AI plc股票交易,Renalytix AI plc股票购买,Renalytix AI plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Renalytix AI plc(RNLX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Renalytix AI plc(RNLX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction